Canon Medical Showcases FDA-Cleared Aquilion Precision at ASTRO 2018

TUSTIN, Calif.—At this year’s American Society of Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas, October 21-24, 2018 (Booth #3737), Canon Medical Systems USA, Inc. will showcase its recently FDA-cleared Aquilion PrecisionTM, the world’s first Ultra-High Resolution CT system. The system can resolve anatomy as small as 150 microns and is designed to provide more than twice the CT resolution as standard systems. Containing an all-new detector as well as tube, gantry and reconstruction technologies, the system may make it possible to help expand visualization of disease thanks to new features that offer improved image detail.  

The Aquilion Precision CT system features innovative dose efficiency with detector channels that are only 0.25 mm thick. This combined with substantial improvements in scintillator quantum efficiency, detector circuitry and other DAS components, result in a dose-efficient detector with ultra-high resolution capabilities. The system features resolution never before seen in CT imaging with one of the industry’s smallest Focal Spot Tube at 0.4 mm x 0.5 mm and the industry’s first routine 1024 x 1024 Reconstruction Matrix. 

“The Aquilion Precision sets a new bar for CT imaging,” said Dominic Smith, senior director, CT, PET/CT, and MR Business Units, Canon Medical Systems USA. “With the highest level of resolution available in the CT market, our customers have the ability to better visualize disease, which can potentially help clinicians in treatment planning.”